Monday, January 7, 2019

Zydus Cadila gets USFDA nod for antipsychotic drug

Zydus Cadila gets USFDA nod for antipsychotic drug Zydus Cadila has received the approval from the United States Food and Drug Administration (USFDA) to market the drug in the strengths of 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, the company said in a BSE filing.

from Moneycontrol Business News http://bit.ly/2Fh1nYr
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...